Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- 22 Jan 2020 Status changed from active, no longer recruiting to completed.
- 11 Jul 2018 Planned End Date changed from 1 May 2017 to 1 Nov 2019.
- 27 May 2016 Status changed from recruiting to active, no longer recruiting.